Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

NCT00832507 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Cicletanine
DRUG: Cicletanine Placebo

Sponsor

Gilead Sciences